Pharmaceuticals can have significant environmental implications, and therefore require an Environmental Risk Assessment (ERA). This entails a thorough examination of the fate and potential hazards posed by these compounds.

We are a specialist CRO providing Environmental Risk Assessment testing in support of EMEA/CHMP/SWP/4447/00 Rev. 1.

careful analysis.

With direct access to your study director throughout, we work with you to optimise both communication and efficiency throughout the lifecycle of your project.

Our team comprises highly expert study directors with a wealth of experience in analytical methods, environmental fate, and ecotoxicology.

We ensure that we are well-prepared to meet and exceed regulatory expectations and keep up to date with evolving guidelines and modifications to existing ones in both the US and EU.

We offer a number of studies to the pharmaceutical industry, including:

  • Acute and Chronic studies

  • Freshwater and marine

  • Ecotoxicology

  • Chronic Daphnia & FELS

  • Higher Tier simulation

  • Biodegradation

  • Metabolite ID

  • Adsorption/Desorption

  • Solubility


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.